Prevalence of Hepatitis-B and Hepatitis-C viruses among HIV infected subjects attending Wad Medani VCT/ART centre, Gezira State, Sudan
Abstract
Objectives: This is a descriptive, prospective, cross-sectional, hospital based study to determine the prevalence of Hepatitis B Virus and Hepatitis C Virus among Human Immunity deficiency Virus infected subjects in the Gezira State of central Sudan.
Materials and Methods: The study was carried out on HIV infected subjects attending Wad Medani VCT/ART centre from Dec. 2010 to March 2011. Epidemiological and demographic characteristics were recorded and participants were interviewed for risk factors of viral hepatitis infection. Blood samples were then collected and tested for HBsAg and HCV antibodies.
Results: A total of 50 subjects were screened with a mean age of 36.39±13.57, 52% were males, HBsAg and HCV antibodies were reactive in 8% and 0% (none) of the studied group, respectively.
Conclusion: This study shows that the prevalence of HBV/HIV co-infection is consistent with both regional and global rates, while HCV/HIV co-infection is low in the studied group.
ملخص:
الأهداف: تحديد شيوع الإصابة بالتهاب الكبد الحموى ب (HBV) و ج (HCV) وسط المرضى المصابين بحمى عوز المناعة المكتسب (HIV ) بولاية الجزيرة وسط السودان.
المرضى و الوسائل: هذه دراسة وصفية توقعية مقطعية مبنية على المستشفى. أجريت الدراسة في المرضى المصابين بحمى عوز المناعة المكتسب المترددين على مستشفى ودمدني مركز ART/VCT في الفترة بين ديسمبر 2010م و حتى مارس 2011م الميزات الوبائية والملامح السكانية رصدت و تمت معاينة المشاركين لمعرفة عوامل الخطورة للإصابة بحمى الكبد. جمعت عينات الدم و تم فحصها للمضاد المناعي HBsAg و مضاد حمى ج HCV .
النتائج: مجموع 50 حالة تم مسحها بمتوسط عمر 36.39 ± 13.57 . نسبة ذكور كانت 52% من الحالات. مضادات HBsAg وHCV كانت متفاعلة في 8% و 0% (لا يوجد) على التوالي.
الخلاصة: أوضحت الدراسة شيوع الاصابة بالتهاب الكبد الحموى ب HBV وسط المصابين HIV تتماشى مع معدلات شيوع الإصابة الإقليمية و العالمية . بينما الاصابه الحمى الكبدي ج (HCV) كان ضعيف فى المجموعه المدروسة.
References
9. UNAIDS: 2009 AIDS epidemic update. UNAIDS/09.36E/JC1700E. Geneva, Joint United Nations Programme on HIV/AIDS AND World Health Organization, November 2009.
10. Dunkle, KL, Stephenson, R, Karita, E, et al. New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data. Lancet 2008; 371:2183.
11. Harania RS, Karuru J, Nelson M, Stebbing J. HIV, hepatitis B and hepatitis C co- infection in Kenya. AIDS. 2008;22:1221–2.
12. Rabeneck, L, Risser, JMH, Murray, NGB, et al. Failure of providers to vaccinate HIV-infected men against hepatitis B: A missed opportunity. Am J Gastroenterol 1993; 88:2015.
13. Hadler, SC, Judson, FN, O'Malley, PM, et al. Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. J Infect Dis 1991; 163:454.
14. Collier, AC, Corey, L, Murphy, VL, Handsfield, HH. Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination. Ann Intern Med 1988; 109:101.
15. Keet, IP, van Doornum, G, Safary, A, Coutinho, RA. Insufficient response to hepatitis B vaccination in HIV-positive homosexual men. AIDS 1992; 6:509.
16. Wong, EK, Bodsworth, NJ, Slade, MA, et al. Response to hepatitis B vaccination in a primary care setting: influence of HIV infection, CD4+ lymphocyte count and vaccination schedule. Int J STD AIDS 1996; 7:490.
17. Harania RS, Karuru J, Nelson M, Stebbing J. HIV, hepatitis B and hepatitis C co- infection in Kenya. AIDS. 2008;22:1221–2.
18. Frommel D, Tekle-Haimanot R, Berhe N, et al. A survey of antibodies to hepatitis C virus in Ethiopia. Am J Trop Med Hyg. 1993;49:435–9.
19. Puoti, M, Airoldi, M, Bruno, R, et al. Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects. AIDS Rev 2002; 4:27.
20. Kellerman, SE, Hanson, DL, McNaghten, AD, Fleming, PL. Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. J Infect Dis 2003; 188:571.
21. Lesi OA, Kehinde MO, Oguh DN, Amira CO. Hepatitis B and C virus infection in Nigerian patients with HIV/AIDS. Niger Postgrad Med J. 2007;14:129–33.
22. Neau, D, Winnock, M, Jouvencel, AC, et al. Occult hepatitis B virus infection in HIV-infected patients with isolated antibodies to hepatitis B core antigen: Aquitaine cohort, 2002-2003. Clin Infect Dis 2005; 40:750.
23. Gandhi, RT, Wurcel, A, Lee, H, et al. Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individuals. Clin Infect Dis 2003; 36:1602.
Rodríguez-Méndez, ML, González-Quintela, A, Aguilera, A, Barrio, E. Prevalence, patterns, and course of past hepatitis B virus infection in intravenous drug users with HIV-1 infection. Am J Gastroenterol 2000; 95:1316-22.
